We are live on
!
Find out more
Axa Portfolio holdings
AUM
$256M
1-Year Est. Return
25.01%
This Fund
S&P 500
This Quarter
Est. Return
+2.39%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$18.8B
AUM Growth
–
Cap. Flow
+$18.6B
Cap. Flow
% of AUM
98.77%
Top 10 Holdings %
Top 10 Hldgs %
14.87%
Holding
1,277
New
1,254
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$355M |
| 2 |
Apple
AAPL
|
+$344M |
| 3 |
Chevron
CVX
|
+$323M |
| 4 |
JPMorgan Chase
JPM
|
+$296M |
| 5 |
ExxonMobil
XOM
|
+$285M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.07% |
| 2 | Financials | 12.69% |
| 3 | Technology | 11.8% |
| 4 | Energy | 9.95% |
| 5 | Industrials | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Alaska Air
ALK
$5.11B
| $25M | 0.13% |
+962,764
| New | +$28.4M |
|
|
ESRX
177
DELISTED
Express Scripts Holding Company
ESRX
| $24.8M | 0.13% |
+402,565
| New | +$24.2M |
|
|
PPLI
178
People Inc
PPLI
$3.12B
| $24.5M | 0.13% |
+2,884,433
| New | +$24.6M |
|
179
AXIS Capital
AXS
$7.81B
| $24.2M | 0.13% |
+529,274
| New | +$23.3M |
|
180
Principal Financial Group
PFG
$24.3B
| $23.6M | 0.13% |
+630,610
| New | +$23.1M |
|
181
Occidental Petroleum
OXY
$55.7B
| $23.4M | 0.12% |
+273,334
| New | +$23.1M |
|
182
iShares Expanded Tech Sector ETF
IGM
$9.57B
| $23.2M | 0.12% |
+1,874,700
| New | +$23.1M |
|
183
Moody's
MCO
$83.7B
| $23.1M | 0.12% |
+378,564
| New | +$23M |
|
184
Kimberly-Clark
KMB
$37.6B
| $23.1M | 0.12% |
+247,616
| New | +$23.9M |
|
185
Baidu
BIDU
$35.7B
| $22.9M | 0.12% |
+242,016
| New | +$22.3M |
|
186
Jazz Pharmaceuticals
JAZZ
$16.1B
| $22.7M | 0.12% |
+329,875
| New | +$20.2M |
|
|
CAVM
187
DELISTED
Cavium, Inc.
CAVM
| $22.6M | 0.12% |
+638,763
| New | +$21.3M |
|
|
STJ
188
DELISTED
St Jude Medical
STJ
| $22.5M | 0.12% |
+492,318
| New | +$21.3M |
|
189
United Therapeutics
UTHR
$26.1B
| $22.3M | 0.12% |
+339,060
| New | +$21.8M |
|
|
MJN
190
DELISTED
Mead Johnson Nutrition Company
MJN
| $22.2M | 0.12% |
+280,352
| New | +$22.5M |
|
191
TransDigm Group
TDG
$70.7B
| $22M | 0.12% |
+140,091
| New | +$21M |
|
192
General Mills
GIS
$20.2B
| $21.9M | 0.12% |
+451,030
| New | +$22.2M |
|
|
PXD
193
DELISTED
Pioneer Natural Resource Co.
PXD
| $21.8M | 0.12% |
+150,767
| New | +$20.1M |
|
194
iShares Core S&P 500 ETF
IVV
$858B
| $21.8M | 0.12% |
+135,395
| New | +$21.9M |
|
195
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.15B
| $21.5M | 0.11% |
+661,311
| New | +$21.4M |
|
196
Baxter International
BAX
$12.8B
| $21.5M | 0.11% |
+571,325
| New | +$21.9M |
|
197
Regeneron Pharmaceuticals
REGN
$72.9B
| $21.3M | 0.11% |
+94,493
| New | +$22M |
|
|
VIAB
198
DELISTED
Viacom Inc. Class B
VIAB
| $21.2M | 0.11% |
+311,863
| New | +$20.8M |
|
199
Johnson Controls International
JCI
$85.1B
| $21.1M | 0.11% |
+562,598
| New | +$21M |
|
200
MGM Resorts International
MGM
$11.7B
| $21M | 0.11% |
+1,420,400
| New | +$20.1M |
|
Similar funds
PHAM
HFRG
EBWM
GCCM
CIA
KAM
ACM
CCA
Axa's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Axa, which disclosed 1,277 positions worth $18.8B. Its ten largest holdings account for 15% of the portfolio.
Its largest position is Pfizer: 12,852,527 shares worth $342M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, followed by Financials and Technology.
- Axa's largest Q2 2013 buy was Pfizer: 12,852,527 shares worth $342M.
- Axa's ten largest holdings make up 15% of its $18.8B portfolio in Q2 2013.
- Axa disclosed 1,277 positions in Q2 2013, its first 13F filing on record.
Based on Axa's 13F filing for Q2 2013, filed 12 Aug 2013.